Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

PURPOSE: In immune-mediated rheumatic diseases (IMRDs), persistence to treatment may be used as a surrogate marker for long-term treatment success. In previous comparisons of persistence to tumor necrosis factor α inhibitors (TNFis), a paucity of data for subcutaneous (SC) golimumab was identified....

Descripción completa

Detalles Bibliográficos
Autores principales: Svedbom, Axel, Storck, Chiara, Kachroo, Sumesh, Govoni, Marinella, Khalifa, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391163/
https://www.ncbi.nlm.nih.gov/pubmed/28435230
http://dx.doi.org/10.2147/PPA.S128665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391163/
https://www.ncbi.nlm.nih.gov/pubmed/28435230
http://dx.doi.org/10.2147/PPA.S128665

Ejemplares similares